Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Robert M Eisner"'
Autor:
Pamela Blair Allen, Xinyan Lu, Qing Chen, Kaitlyn L. Kane, Joan S Chmiel, Liron Barnea Slonim, Madina Sukhanova, Hatice Savas, Andrew M Evens, Ranjana Advani, Barbara Pro, Reem Karmali, Brett Palmer, Robert Bayer, Robert M Eisner, Eric Mou, Gary Dillehay, Leo I Gordon, Jane N Winter
Publikováno v:
Blood advances.
In a multicenter, phase II investigator-initiated trial of sequential pembrolizumab and AVD, nearly two-thirds of patients with untreated unfavorable or advanced stage classic Hodgkin Lymphoma (cHL) achieved PET-defined complete or near complete meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::851da37a8dbfec5d0955635bc5646d09
https://pubmed.ncbi.nlm.nih.gov/36083129
https://pubmed.ncbi.nlm.nih.gov/36083129
Autor:
Sachdev P. Thomas, Bahman Emami, Craig C. Hofmeister, Joseph I. Clark, Abdul Choudhury, Deanne M. R. Lathers, John Norton, Guy J. Petruzzelli, Ann Lau, Robert M. Eisner, M. Rita I. Young
Publikováno v:
American Journal of Clinical Oncology. 32:396-400
Background: This phase I study was designed to determine the maximum tolerated dose (MTD) and preliminary efficacy of docetaxel with concurrent radiotherapy (RT), in high-risk squamous cell carcinoma of the head and neck. Patients and Methods: Eligib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b51e25d7f2e8e76ffb9c947fe4e1b83
https://doi.org/10.1097/coc.0b013e31818da9c7
https://doi.org/10.1097/coc.0b013e31818da9c7
Publikováno v:
Cancer investigation. 22(3)
High dose bolus interleukin 2 (IL-2) used in the treatment of metastatic melanoma and renal cell carcinoma is known to have the potential for serious cardiac toxicity. At our institution 2 of 57 (3.5%) patients developed IL-2 induced myocarditis. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaac8e6cbbe52c752b97ff36a9da9eb9
https://pubmed.ncbi.nlm.nih.gov/15493361
https://pubmed.ncbi.nlm.nih.gov/15493361